The effect of ıntravesical prostatic protrusion in patients with benign prostatic hyperplasia: controlled, clinical study
Citation
Kadihasanoglu, M., Aydin, M., Taskiran, M., & Kendirci, M. (2019). The Effect of Intravesical Prostatic Protrusion in Patients with Benign Prostatic Hyperplasia: Controlled, Clinical Study. Urologia internationalis, 103(2), 180-186.Abstract
Background: Although prostate cancer releases more prostate-specific antigen (PSA) per unit of prostate volume (PV), data are limited regarding the association between intravesical prostatic protrusion (IPP) and the PSA level. Objectives: The study aim was to evaluate the IPP effect in patients with benign prostatic hyperplasia. Method: This study included patients with (n = 119) and without (n = 121) IPP. The age, International Prostate Symptom Score (IPSS), PSA level, maximum and average flow rates, PV, hematuria, urinary retention, and post-void residual (PVR) volume were compared between the 2 groups. Results: The mean ages were similar between the 2 groups (66.56 +/- 8.67 and 66.92 +/- 8.7 years, respectively, p = 0.747), and there were no statistically significant differences in the IPSS, maximum and average flow rates, hematuria, PVR volume, and urinary retention means (p > 0.05). However, the IPP patients had lower total PSA (tPSA) and free PSA (fPSA) levels than those without IPP (3.55 [4.18] vs. 5.26 [5.24] ng/mL, p = 0.013 and 0.7 [1.09] vs. 1.05 [1.23] ng/mL, p = 0.029, respectively). Moreover, there were strong positive correlations between the IPP grade and the tPSA and fPSA levels (r = 0.262, p = 0.001 and r = 0.254, p = 0.002 respectively). Conclusions: This study demonstrated that IPP results in a decreased PSA level, even with a higher PV. (C) 2019 S. Karger AG, Basel
Source
Urologia InternationalisVolume
103Issue
2Collections
Related items
Showing items related by title, author, creator and subject.
-
Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
Balaban, Muhsin; Ozkaptan, Orkunt; Sevinc, Cuneyd; Boz, Mustafa Yucel; Horuz, Rahim; Kafkasli, Alper; Canguven, Onder (Brazilian Soc Urol, 2020)Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We ... -
A clinical trial comparing BiVap (Richard Wolf®) saline vaporization of the prostate vs. TwisterTM Diode Laser System in the treatment of benign prostatic obstruction between prostate volume 90 to 150 ml
Karakose, Ayhan; Yitgin, Yasin (SAGE Publications, 2021)Introduction: To evaluate the efficacy, safety and postoperative outcomes of the BiVap and Twister systems with benign prostatic obstruction (BPO) in prostate volüm between 90–150 ml. Methods: In total, we included 131 ... -
Transarterial embolization of prostate with biodegradable flutamide-loaded PLA/PLGA microspheres for benign prostate hyperplasia: preliminary study in a normal swine model
Nurili, F.; Acar, T.; Derman, S.; Bas, A.; Yurdaisik, Isil; Ozkanli, S.; Caymaz, I.; Cakiroglu, H.; Aras, O. (Science Direct, 2019)Purpose: To prospectively evaluate whether transarterial embolization with biodegradable flutamide-loaded PLA/PLGA microspheres with sustained-release properties in the prostate of swine can induce shrinkage in the volume ...